TrialThe oncologist2024

Longitudinal patient-reported outcomes on genotype-guided irinotecan dosing: feasibility and clinical relevance.

Jonathan D Sorah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.